S

Shasun Pharmaceuticals Ltd(Merged)

SHASUNPHAR NSE
This stock has been delisted or merged and is no longer actively traded.

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

5
  • Stock is trading at 6.38 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.9% over past five years.
  • Company has a low return on equity of 11.6% over last 3 years.
  • Dividend payout has been low at 11.6% of profits over last 3 years

Growth Rate

Revenue Growth
3% lower than 3Y
Net Income Growth
107% higher than 3Y

Quarterly Results

Particulars Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015
Sales
272
271
276
227
297
325
363
314
320
325
358
334
339
Expenses
241
251
253
232
266
290
323
297
301
292
317
303
302
Operating Profit
31
20
23
-5
30
35
40
17
19
33
41
31
37
OPM %
11%
7%
8%
-2.2%
10%
11%
11%
5%
6%
10%
11%
9%
11%
Other Income
11
8
7
9
7
3
3
2
4
2
12
1
4
Interest
6
10
5
8
9
11
14
12
12
16
13
12
12
Depreciation
13
12
16
13
15
15
16
12
10
12
13
14
15
PBT
21
6
9
-17
13
13
13
-5
1
7
27
5
15
Tax %
17%
-28%
-50%
-61%
0%
-1%
23%
0%
2%
0%
23%
24%
11%
Net Profit
18
8
13
-7
13
13
10
-5
0
6
22
4
13
EPS in Rs
3.22
1.49
2.34
-1.16
2.36
2.3
1.84
-0.8
0.04
1.02
3.69
0.57
1.95
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015TTM
Sales
348
763
809
749
784
834
1,066
1,084
1,207
1,314
1,356
Expenses
292
689
797
863
771
763
943
967
1,098
1,195
1,214
Operating Profit
55
73
12
-113
13
71
123
117
109
119
141
OPM %
16%
10%
1.5%
-15%
1.7%
9%
12%
11%
9%
9%
10%
Other Income
17
19
59
32
57
22
41
18
23
21
19
Interest
5
10
15
22
30
32
44
32
50
63
52
Depreciation
23
26
31
38
38
38
41
53
59
47
54
PBT
43
57
24
-141
2
24
80
50
23
30
54
Tax %
15%
8%
-1%
-3%
-88%
-13%
-26%
-5%
-32%
21%
—
Net Profit
37
53
25
-137
4
27
101
53
30
24
45
EPS in Rs
—
10.94
5.1
-28.38
0.78
5.49
18.25
9.37
5.34
3.95
7.23
Div. Payout %
22%
16%
20%
0%
128%
5%
13%
16%
19%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Equity Capital
10
10
10
10
10
10
11
11
11
12
Reserves
168
212
230
97
108
74
211
261
291
367
Borrowings
79
192
257
339
327
329
353
506
692
739
Other Liabilities
94
219
167
219
219
235
285
266
332
364
Total Liabilities
351
632
663
664
663
648
860
1,044
1,327
1,482
Fixed Assets
175
214
255
269
244
248
278
365
383
529
CWIP
2
21
55
35
30
12
52
81
114
76
Investments
5
0
0
0
0
0
0
1
7
16
Other Assets
169
397
352
360
389
387
529
598
823
861
Total Assets
351
632
663
664
663
648
860
1,044
1,327
1,482
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Operating
31
-6
58
-34
37
59
51
35
40
84
Investing
-32
-78
-106
-21
10
-32
-77
-161
-164
-145
Financing
-9
91
43
54
-40
-28
32
117
131
51
Net Cash Flow
-9
8
-5
0
7
-1
5
-9
7
-9
Free Cash Flow
5
-90
-48
-60
46
24
-30
-126
-152
-63
CFO/OP
71
-3
513
29
294
84
50
30
42
79
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Debtor Days
80
90
81
91
90
69
79
89
106
97
Inventory Days
115
182
103
97
89
108
90
113
122
128
Days Payable
83
200
105
158
152
137
141
140
159
152
Cash Conversion Cycle
112
72
79
30
27
40
28
62
69
72
Working Capital Days
94
90
89
72
77
64
63
89
103
118
ROCE %
—
20%
9%
-27%
3%
13%
19%
12%
8%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Shasun Pharmaceuticals Ltd(Merged) insights

61 extracted metrics + investor summaries across FY04–FY15.

Log in — free

Documents

Frequently Asked Questions about Shasun Pharmaceuticals Ltd(Merged)

What does Shasun Pharmaceuticals Ltd(Merged) do?
Shasun Pharmaceuticals Limited (SPL) is an India-based company, which is a supplier of development and manufacturing services for intermediates, active pharmaceutical ingredients (API) and finished dosage. The Company is also into product development and provides contract research and manufacturi...
Where is Shasun Pharmaceuticals Ltd(Merged) (SHASUNPHAR) listed?
Shasun Pharmaceuticals Ltd(Merged) trades as SHASUNPHAR on the NSE.
Which sector does Shasun Pharmaceuticals Ltd(Merged) belong to?
Shasun Pharmaceuticals Ltd(Merged) is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Shasun Pharmaceuticals Limited (SPL) is an India-based company, which is a supplier of development and manufacturing services for intermediates, active pharmaceutical ingredients (API) and finished dosage. The Company is also into product development and provides contract research and manufacturing services.

Website shasun.com
Face Value ₹ 2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHASUNPHAR.md for Shasun Pharmaceuticals Ltd(Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List